← QL Research Library
WATCHLRCXLOW conviction · invalidated✦ Commissioned

LRCX: A $25B Floor Under a Broken Chart — WATCH at $219.21

Published · entry price $219.21 · machine-generated by the QuantLogix Thesis Engine and graded publicly at T+7/30/90 days · LRCX charts & signals →

LRCX trades at $219.21 after a -34% one-month drawdown that was answered on Nov 5 with a $25B buyback authorization and an 8%+ two-session pop. The 5-factor engine reads Sell, but both the long and short cohorts are inverted at 38.1% win over 3,076 resolved signals — a coin flip with no priced edge — and the name's cohort (+0.18% over 194 signals) fails the +5% alpha bar, so WATCH is the honest verdict. The $194.69 consensus Sell target looks stale against memory demand through 2030 and robust cash generation; a close below $185.00 flips this bearish, a close above $240.00 reopens the bull.

Price claim ladder — entry vs monitored trigger levels
$185 · invalidates · FIRED$194.69 · FIRED$240$205entry $219.21

Thesis

Evidence Graph4 of 4 claims linked · 6 preserved sources
Claim coverage4 / 4claims with evidence
Directional edges77 support · 0 challenge
Freshness5 / 6Latest dated source 11/09/2026
ConvictionLOW0 recorded changes

This graph uses only evidence frozen into the thesis at publication on 11/09/2026. “Retrieved source passage” is the preserved grounding excerpt the engine saw; “published note passage” is thesis context, not a source quote. Missing edges and dates remain visible.

C1Invalidation ruleTriggered
3 linked sources

LRCX holds above $185.00 through the T+30 grading date — the invalidation is deliberately set wider than the $190–195 implied post-buyback low zone, per the engine's SPGI lesson on stops placed exactly at obvious levels; a sustained close b

G1SupportsExternal sourceOpen source
LRCX Gains 8% on a $25B Buyback Plan: Is the Stock Worth Holding Now?
Published · finance.yahoo.com

The $25B repurchase authorization and 8.2% Friday rally suggest a corporate bid forming a floor near the pre-announcement lows.

Retrieved source passage
LRCX Gains 8% on a $25B Buyback Plan: Is the Stock Worth Holding Now? LRCX Gains 8% on a $25B Buyback Plan: Is the Stock Worth Holding Now? Anirudha Bhagat Mon, November 9, 2026 at 7:06 AM EST 6 min read Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational. Lam Research Corporation LRCX shares rose 8.2% last Friday, following the company's announcement of a massive $25 billion share repurchase authorization on Nov. 5. The move offered some relief
G4SupportsExternal sourceOpen source
Lam Research: Down 29% Since My Sell Call, But The Math Has Changed (Upgrade) (LRCX) Seeking Alpha
Published · seekingalpha.com

A formerly bearish analyst upgraded after the 29% decline, arguing the valuation math has changed — evidence the downside below the low zone is contested.

Retrieved source passage
Lam Research: Down 29% Since My Sell Call, But The Math Has Changed (Upgrade) (LRCX) Seeking Alpha Lam Research: Down 29% Since My Sell Call, But The Math Has Changed (Upgrade) Oct 25, 2026, 2:41 PM ET Lam Research Corporation (LRCX) Stock, LRCX:CA Stock AMAT, ASML, AMAT:CA, ASML:CA, ASMLF 1 Comment 1 Like Bashar Issa Summary - Lam Research Corporation was previously rated Sell due to high valuations; shares have since declined 29%. - The valuation landscape for LRCX stock has shifted significantly following the recent price correction. - A $200 billion wafer fabrication boom is a key industry catalyst impacting LRCX’s outlook. - The investment thesis is now reassessed in light of cha
G3Context matchExternal sourceOpen source
Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here TIKR.com
Published · tikr.com

The 34% monthly drawdown quantifies how fast this name travels when it breaks; it sizes the tail risk below the floor rather than resolving direction.

Retrieved source passage
Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here TIKR.com Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here David Hanson • 5 minute read Reviewed by: David Hanson Last updated Nov 3, 2026 @sasirin pamai's Images via Canva Key Takeaways - Lam Research stock is down 34% in the past month. A record September quarter came with a December-quarter guide only in line with estimates, and fears about AI spending hit Applied Materials and the rest of the chip-equipment group too. - Management said shortages of certain components held the guide back, and SK hynix expects memory demand to outrun supply through 2030. - Analysts expect Lam’s EPS to rise abou
C2Triggered
3 linked sources

LRCX does not trade down to the $194.69 sell-side consensus price target during the T+30 window; tagging that level confirms the consensus Sell is correctly priced.

G1SupportsExternal sourceOpen source
LRCX Gains 8% on a $25B Buyback Plan: Is the Stock Worth Holding Now?
Published · finance.yahoo.com

The buyback and dividend declaration provide a demand offset the consensus target may predate.

Retrieved source passage
LRCX Gains 8% on a $25B Buyback Plan: Is the Stock Worth Holding Now? LRCX Gains 8% on a $25B Buyback Plan: Is the Stock Worth Holding Now? Anirudha Bhagat Mon, November 9, 2026 at 7:06 AM EST 6 min read Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational. Lam Research Corporation LRCX shares rose 8.2% last Friday, following the company's announcement of a massive $25 billion share repurchase authorization on Nov. 5. The move offered some relief
G4SupportsExternal sourceOpen source
Lam Research: Down 29% Since My Sell Call, But The Math Has Changed (Upgrade) (LRCX) Seeking Alpha
Published · seekingalpha.com

The upgrade thesis (valuation reset, $200B wafer fab boom) argues the sell-side consensus has not caught up to the new math.

Retrieved source passage
Lam Research: Down 29% Since My Sell Call, But The Math Has Changed (Upgrade) (LRCX) Seeking Alpha Lam Research: Down 29% Since My Sell Call, But The Math Has Changed (Upgrade) Oct 25, 2026, 2:41 PM ET Lam Research Corporation (LRCX) Stock, LRCX:CA Stock AMAT, ASML, AMAT:CA, ASML:CA, ASMLF 1 Comment 1 Like Bashar Issa Summary - Lam Research Corporation was previously rated Sell due to high valuations; shares have since declined 29%. - The valuation landscape for LRCX stock has shifted significantly following the recent price correction. - A $200 billion wafer fabrication boom is a key industry catalyst impacting LRCX’s outlook. - The investment thesis is now reassessed in light of cha
G3Context matchExternal sourceOpen source
Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here TIKR.com
Published · tikr.com

An in-line December guide and AI-spending fears hitting the whole equipment group are the legitimate core of the bear consensus — context for why the target is not obviously wrong.

Retrieved source passage
Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here TIKR.com Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here David Hanson • 5 minute read Reviewed by: David Hanson Last updated Nov 3, 2026 @sasirin pamai's Images via Canva Key Takeaways - Lam Research stock is down 34% in the past month. A record September quarter came with a December-quarter guide only in line with estimates, and fears about AI spending hit Applied Materials and the rest of the chip-equipment group too. - Management said shortages of certain components held the guide back, and SK hynix expects memory demand to outrun supply through 2030. - Analysts expect Lam’s EPS to rise abou
C3
3 linked sources

LRCX closes above $240.00 within the T+30 window, extending the buyback-driven recovery through the initial gap zone toward the implied ~$288 pre-selloff level and the ~$290 Bernstein target.

G1SupportsExternal sourceOpen source
LRCX Gains 8% on a $25B Buyback Plan: Is the Stock Worth Holding Now?
Published · finance.yahoo.com

An 8.2% single-session rally on the buyback shows the market's capacity to re-rate the name quickly on capital-return news.

Retrieved source passage
LRCX Gains 8% on a $25B Buyback Plan: Is the Stock Worth Holding Now? LRCX Gains 8% on a $25B Buyback Plan: Is the Stock Worth Holding Now? Anirudha Bhagat Mon, November 9, 2026 at 7:06 AM EST 6 min read Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational. Lam Research Corporation LRCX shares rose 8.2% last Friday, following the company's announcement of a massive $25 billion share repurchase authorization on Nov. 5. The move offered some relief
G2SupportsExternal sourceOpen source
Why is Lam Research stock surging today? By Investing.com
Published · investing.com

The follow-through 6.9% surge and CFO commentary on strong positioning at technology inflections support continuation rather than a one-day squeeze.

Retrieved source passage
Why is Lam Research stock surging today? By Investing.com Why is Lam Research stock surging today? Editor Vlad Schepkov Stock Markets Editor Vlad Schepkov Published Nov 09, 2026, 10:12 AM Why is Lam Research stock surging today? Investing.com -- Lam Research stock is surging 6.9% in morning trading today, extending a recovery from last week’s punishing semiconductor selloff, as investors continue to reward the company’s board-approved $25 billion share repurchase authorization — announced on November 5 — alongside a declared quarterly cash dividend of $0.33 per share. CFO Doug Bettinger stated that "our strong positioning at key technology inflections and robust cash generation give us con
G3Context matchExternal sourceOpen source
Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here TIKR.com
Published · tikr.com

Bernstein's 53% upside call frames the bull path but is one analyst's view, not confirmation.

Retrieved source passage
Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here TIKR.com Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here David Hanson • 5 minute read Reviewed by: David Hanson Last updated Nov 3, 2026 @sasirin pamai's Images via Canva Key Takeaways - Lam Research stock is down 34% in the past month. A record September quarter came with a December-quarter guide only in line with estimates, and fears about AI spending hit Applied Materials and the rest of the chip-equipment group too. - Management said shortages of certain components held the guide back, and SK hynix expects memory demand to outrun supply through 2030. - Analysts expect Lam’s EPS to rise abou
C4
1 linked source

LRCX closes below $205.00 before T+30, confirming the technical breakdown (RSI 34.1, MACD -5.535, 5-day momentum -13.45%) overwhelms the buyback bid and the path toward the $194.69 consensus target reopens.

G3SupportsExternal sourceOpen source
Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here TIKR.com
Published · tikr.com

The December guide was only in line despite a record September quarter, and AI-capex fears hit Applied Materials and the whole group — the fundamental trigger for a renewed leg down.

Retrieved source passage
Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here TIKR.com Lam Research Lost 34% in a Month. Bernstein Sees 53% Upside From Here David Hanson • 5 minute read Reviewed by: David Hanson Last updated Nov 3, 2026 @sasirin pamai's Images via Canva Key Takeaways - Lam Research stock is down 34% in the past month. A record September quarter came with a December-quarter guide only in line with estimates, and fears about AI spending hit Applied Materials and the rest of the chip-equipment group too. - Management said shortages of certain components held the guide back, and SK hynix expects memory demand to outrun supply through 2030. - Analysts expect Lam’s EPS to rise abou

Unmapped source register

2 sources

These links were preserved in the note but cannot be honestly assigned to a specific claim.

S5UnmappedExternal sourceOpen source
finance.yahoo.com
Publication date not preserved · finance.yahoo.com
Published note passage
t one-month round trips in large-cap semis: a -34% drawdown into early November ([TIKR, G3]), then a $25B buyback authorization on Nov 5 ([Yahoo Finance, G1]) that produced an 8.2% Friday rally and a further 6.9% surge Monday morning…
S6UnmappedQuantLogix coverageOpen source
quantlogix.ai
Published · quantlogix.ai
Published note passage
Our prior coverage flagged a 100/100 composite on June 2 ([QuantLogix]) — the stock is far below that regime, and that call's aging is part of why the bar exists.

What changed

Complete, timestamped thesis history.

Review in Thesis Lab →
  1. Invalidation rule triggered
    The LRCX thesis is now closed as the price has breached the established invalidation level. Market performance through the T+30 window confirms the trade parameters are no longer met. · $217.78
  2. Thesis published
    WATCH · LOW conviction

LRCX: A $25B Floor Under a Broken Chart — WATCH at $219.21

Setup

Lam Research sits at $219.21 after one of the more violent one-month round trips in large-cap semis: a -34% drawdown into early November (TIKR, G3), then a $25B buyback authorization on Nov 5 (Yahoo Finance, G1) that produced an 8.2% Friday rally and a further 6.9% surge Monday morning alongside a $0.33 quarterly dividend (Investing.com, G2). Our prior coverage flagged a 100/100 composite on June 2 (QuantLogix) — the stock is far below that regime, and that call's aging is part of why the bar exists.

The engine's verdict inputs are unusual: the 5-factor engine reads Sell (42/100, 40% calibrated win probability), but both the long and short cohorts are inverted at 38.1% win over 3,076 resolved signals — the engine is explicitly pricing this as a coin flip with negative edge in either direction. The name's own cohort measures +0.18% over 194 signals with three judged months all negative (June -3.53%, July -5.38%, October -5.53%; 95% CI low -1.38%), nowhere near the +5% alpha bar. Under the standing policy, a BULLISH verdict cannot run against a bearish engine read or an inverted long cohort, and a BEARISH verdict requires a verified short cohort — which is inverted. WATCH is the only honest output, and the record prices the caution: bearish calls running against these live reads were right only 30% of the time, and the engine's graded BEARISH calibration is 11/33 (avg -3.2%). Shorting here has historically been a losing trade against this stack.

Evidence & Data

InputReadDirectional weight
5-factor engineSell, 42/100, 40% win probBearish, but weakly calibrated
Long cohortInverted, 38.1% win / 3,076 signalsBlocks BULLISH
Short cohortInverted, 38.1% win / 3,076 signalsBlocks verified BEARISH
RSI / MACD34.1 / -5.535Oversold-adjacent, momentum broken
5d vs 20d momentum-13.45% vs +3.03%, SMA bullishInternally contradictory
News sentiment0.3 (positive)Modestly bullish
Analyst consensusSell, PT $194.69 (=-11.2% vs live)Bearish
Options flowNo whale ordersNo conviction either way

The technical stack contradicts itself, and I suspect staleness: a -13.45% 5-day read is hard to reconcile with an +8.2% Friday and +6.9% Monday pop unless the platform snapshot predates the buyback rally. Deriving the path from the retrieved sources: $219.21 ÷ 1.082 ÷ 1.069 ≈ $190 implied pre-buyback (Nov 5), and $190 ÷ 0.66 ≈ $288 implied pre-selloff. Bernstein's 53% upside from the early-November price implies a ~$290 target (G3) — nearly back to the pre-selloff high. Note a data-quality flag: the platform's consensus row cites a "$277.46" reference price that appears stale versus the $219.21 live read.

The consensus view and the variant perception. Sell-side consensus is Sell with a $194.69 target, anchored on an in-line December guide and AI-capex fear. I believe the market is mispricing three things: (1) the guide was capped by component shortages, not demand — management said so explicitly, and SK hynix expects memory demand to outrun supply through 2030 (G3); (2) the $25B buyback plus a declared dividend is a supply-absorbing corporate bid at precisely the level consensus targets (G1, G2); (3) a formerly bearish analyst has upgraded on the valuation reset and a $200B wafer-fab boom (Seeking Alpha, G4). The bull-bear target spread (~$290 vs $194.69) is $95, or 43% of spot — disagreement this wide with inverted cohorts on both sides is the textbook setup for WATCH. On macro: the retrieved evidence is thin — I have group-level AI-capex derating evidence (G3, G4) but no rates or rotation data in this pull, and I will not fabricate a macro read; what cycle evidence exists (memory tightness to 2030, fab-capex boom) cuts against the derating.

Scenario Analysis

ScenarioProbabilityPrice pathThesis impact

| Bull re-rating

What Changes Our Mind

Our WATCH stance would flip to a definitive BULLISH rating if we observe a sustained breakout above the $245 technical resistance level, coinciding with a transition of the long cohort into positive territory. Such a move would suggest that the market has successfully reconciled the supply-side constraints mentioned by management with the long-term memory demand cycle through 2030. Conversely, we would invalidate the WATCH view and pivot to a BEARISH stance if the stock fails to hold the $200 support floor following the buyback-driven volatility. An inability to maintain this level, particularly if the 5-factor engine’s win probability increases above 55% while the short cohort stabilizes into a positive conviction read, would confirm that the buyback has failed to provide a structural safety net. Finally, any evidence of a material downward revision in HBM (High Bandwidth Memory) capex projections from key industry partners would override our current assessment of structural demand, signaling that the supply-constrained growth thesis is no longer the primary driver of Lam Research’s valuation.

Related QuantLogix coverage

More from QL Research

Share this research

Browse the full graded library →

QL Research is machine-generated educational market commentary, not investment advice. QuantLogix is not a registered investment adviser, broker-dealer, or financial planner. Theses, claims, verdicts, and grades are quantitative model outputs published for transparency and education; they are not recommendations to buy or sell any security. Markets involve substantial risk of loss. Past graded performance does not guarantee future results.